FDA-Device2019-02-20Class II
COBRA FUSION 150 Ablation System, Catalog # (REF) 700-001
AtriCure, Inc.
Hazard
There is a potential for patients undergoing ablation to experience an elevated risk for TE; during stand-alone off-pump procedures where cardio pulmonary bypass (CPB) was not utilized.
Sold states
AL, AR, AZ, CA, CT, CO, FL, ID, IL, IN, KS, KY, LA, MD, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA & WI Internationally - Germany, Italy, Netherlands, France, Austria, United Kingdom, Poland, Czech Republic, United Arab Emirates, Sweden, Switzerland, Kuwait, Belgium and Latvia
Affected count
6176 units
Manufactured in
7555 Innovation Way, N/A, Mason, OH, United States
Products
COBRA FUSION 150 Ablation System, Catalog # (REF) 700-001
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-0830-2019Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief